يعرض 1 - 10 نتائج من 63 نتيجة بحث عن '"(1"', وقت الاستعلام: 2.28s تنقيح النتائج
  1. 1

    المساهمون: Pathology/molecular and cellular medicine, Diabetes Clinic, Diabetes Pathology & Therapy

    المصدر: The lancet : international edition

  2. 2
  3. 3
  4. 4
  5. 5

    المساهمون: University of Virginia [Charlottesville], Department of Molecular Medicine [Tampa], University of South Florida [Tampa] (USF), Stanford School of Medicine [Stanford], Stanford Medicine, Stanford University-Stanford University, Mayo Clinic [Rochester], Harvard Medical School [Boston] (HMS), Université de Lorraine (UL)

    المصدر: New England Journal of Medicine
    New England Journal of Medicine, Massachusetts Medical Society, 2019, 381 (18), pp.1707-1717. ⟨10.1056/NEJMoa1907863⟩

  6. 6
  7. 7

    المصدر: Medicine

  8. 8

    المساهمون: Di Bartolo, P., Nicolucci, A., Cherubini, V., Iafusco, D., Scardapane, M., Rossi, M. C.

    المصدر: Acta Diabetologica. 54:393-402

  9. 9

    المصدر: BMC Endocrine Disorders
    BMC Endocrine Disorders, Vol 19, Iss 1, Pp 1-13 (2019)

  10. 10

    المصدر: BMC Endocrine Disorders
    BMC Endocrine Disorders, Vol 19, Iss 1, Pp 1-8 (2019)
    Agesen, R M, Alibegovic, A C, Andersen, H U, Beck-Nielsen, H, Gustenhoff, P, Hansen, T K, Hedetoft, C, Jensen, T, Juhl, C B, Lerche, S S, Nørgaard, K, Parving, H-H, Tarnow, L, Thorsteinsson, B & Pedersen-Bjergaard, U 2019, ' The effect of insulin degludec on risk of symptomatic nocturnal hypoglycaemia in adults with type 1 diabetes and high risk of nocturnal severe hypoglycaemia (the HypoDeg trial) : study rationale and design ', BMC Endocrine Disorders, vol. 19, no. 1, 78 . https://doi.org/10.1186/s12902-019-0408-xTest
    Agesen, R M, Alibegovic, A C, Andersen, H U, Beck-Nielsen, H, Gustenhoff, P, Hansen, T K, Hedetoft, C, Jensen, T, Juhl, C B, Lerche, S S, Nørgaard, K, Parving, H-H, Tarnow, L, Thorsteinsson, B, Pedersen-Bjergaard, U & Bariatri og Diabetes 2019, ' The effect of insulin degludec on risk of symptomatic nocturnal hypoglycaemia in adults with type 1 diabetes and high risk of nocturnal severe hypoglycaemia (the HypoDeg trial) : study rationale and design ', BMC Endocrine Disorders, vol. 19, 78 . https://doi.org/10.1186/s12902-019-0408-xTest
    Agesen, R M, Alibegovic, A C, Andersen, H U, Beck-Nielsen, H, Gustenhoff, P, Hansen, T K, Hedetoft, C, Jensen, T, Juhl, C B, Lerche, S S, Nørgaard, K, Parving, H-H, Tarnow, L, Thorsteinsson, B & Pedersen-Bjergaard, U 2019, ' The effect of insulin degludec on risk of symptomatic nocturnal hypoglycaemia in adults with type 1 diabetes and high risk of nocturnal severe hypoglycaemia (the HypoDeg trial) : study rationale and design ', BMC Endocrine Disorders, vol. 19, 78 . https://doi.org/10.1186/s12902-019-0408-xTest
    Agesen, R M, Alibegovic, A C, Andersen, H U, Beck-Nielsen, H, Gustenhoff, P, Hansen, T K, Hedetoft, C, Jensen, T, Juhl, C B, Lerche, S S, Nørgaard, K, Parving, H-H, Tarnow, L, Thorsteinsson, B & Pedersen-Bjergaard, U 2019, ' The effect of insulin degludec on risk of symptomatic nocturnal hypoglycaemia in adults with type 1 diabetes and high risk of nocturnal severe hypoglycaemia (the HypoDeg trial): study rationale and design ', BMC Endocrine Disorders, vol. 19, 78, pp. 1-8 . https://doi.org/10.1186/s12902-019-0408-xTest

    وصف الملف: application/pdf